These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Extracellular histones promote fibrinolysis by single-chain urokinase-type plasminogen activator in a factor seven activating protease-dependent way. Semeraro F, Ammollo CT, Semeraro N, Colucci M. Thromb Res; 2020 Dec; 196():193-199. PubMed ID: 32891905 [Abstract] [Full Text] [Related]
3. Absence of synergism between tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (scu-PA) and urokinase on clot lysis in a plasma milieu in vitro. Collen D, De Cock F, Demarsin E, Lijnen HR, Stump DC. Thromb Haemost; 1986 Aug 20; 56(1):35-9. PubMed ID: 3095946 [Abstract] [Full Text] [Related]
5. Pro-urokinase: a study of its stability in plasma and of a mechanism for its selective fibrinolytic effect. Pannell R, Gurewich V. Blood; 1986 May 20; 67(5):1215-23. PubMed ID: 3083889 [Abstract] [Full Text] [Related]
6. Factor VII and single-chain plasminogen activator-activating protease: activation and autoactivation of the proenzyme. Kannemeier C, Feussner A, Stöhr HA, Weisse J, Preissner KT, Römisch J. Eur J Biochem; 2001 Jul 20; 268(13):3789-96. PubMed ID: 11432747 [Abstract] [Full Text] [Related]
9. Protection of single-chain urokinase-type plasminogen activator (scu-PA) in aprotinin treated cardiac surgical patients undergoing cardiopulmonary bypass. Spannagl M, Dooijewaard G, Dietrich W, Kluft C. Thromb Haemost; 1995 May 20; 73(5):825-8. PubMed ID: 7482410 [Abstract] [Full Text] [Related]
10. A protease isolated from human plasma activating factor VII independent of tissue factor. Römisch J, Feussner A, Vermöhlen S, Stöhr HA. Blood Coagul Fibrinolysis; 1999 Dec 20; 10(8):471-9. PubMed ID: 10636458 [Abstract] [Full Text] [Related]
11. An analysis of the activators of single-chain urokinase-type plasminogen activator (scu-PA) in the dextran sulphate euglobulin fraction of normal plasma and of plasmas deficient in factor XII and prekallikrein. Binnema DJ, Dooijewaard G, Turion PN. Thromb Haemost; 1991 Feb 12; 65(2):144-8. PubMed ID: 1905069 [Abstract] [Full Text] [Related]
13. Effect of standard heparin and a low molecular weight heparin on thrombolytic and fibrinolytic activity of single-chain urokinase plasminogen activator in vitro. Lourenço DM, Dosne AM, Kher A, Samama M. Thromb Haemost; 1989 Nov 24; 62(3):923-6. PubMed ID: 2556812 [Abstract] [Full Text] [Related]
15. Activation of coagulation factor VII by tissue-type plasminogen activator. Tsujioka H, Suehiro A, Kakishita E. Am J Hematol; 1999 May 24; 61(1):34-9. PubMed ID: 10331509 [Abstract] [Full Text] [Related]
16. Factor seven activating protease (FSAP): does it activate factor VII? Stavenuiter F, Dienava-Verdoold I, Boon-Spijker MG, Brinkman HJ, Meijer AB, Mertens K. J Thromb Haemost; 2012 May 24; 10(5):859-66. PubMed ID: 22235940 [Abstract] [Full Text] [Related]
17. The nature of synergy between tissue-type and single chain urokinase-type plasminogen activators. Fry ET, Mack DL, Sobel BE. Thromb Haemost; 1989 Nov 24; 62(3):909-16. PubMed ID: 2512679 [Abstract] [Full Text] [Related]
18. Nerve growth factor-gamma activates soluble and receptor-bound single chain urokinase-type plasminogen activator. Wolf BB, Vasudevan J, Henkin J, Gonias SL. J Biol Chem; 1993 Aug 05; 268(22):16327-31. PubMed ID: 8393859 [Abstract] [Full Text] [Related]